Androgens and prostate cancer: Are the descriptors valid?

Cancer Biology and Therapy

Volumn 4, Issue 1, 2005, Pages 4-5

  Roy Burman, Pradip ^a   Tindall, Donald J ^b   Robins, Diane M ^c   Greenberg, Norman M ^d   Hendrix, Mary J C ^e   Mohla, Suresh ^f   Getzenberg, Robert H ^g   Isaacs, John T ^h   Pienta, Kenneth J ⁱ  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

ⁱ UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANTIANDROGEN; ANTINEOPLASTIC AGENT;

ARTICLE; HORMONE DEPENDENCE; HUMAN; MALE; PROSTATE CANCER; PROTEIN DEPLETION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; LETTER; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTATE TUMOR;

ANDROGEN ANTAGONISTS; ANDROGENS; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION;

EID: 20544438390     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.4.1.1563     Document Type: Article

References (3)

1. Tindall D, Horne FM, Hruszkewycz A, Mohla S, et al. Symposium on androgen in prostate cancer. Cancer Res 2004; 64:7178-80.
2. Debes, JD, Tindall DJ. Mechanisms of androgen-refractory prostate cancer. New Engl J Med 2004; 351: 1488-90
3. Isaacs JT, Isaacs WB. Androgen receptor outwits prostate cancer drugs. Nature Med 2004; 10: 26-7.